Casey Woodring
Stock Analyst at J.P. Morgan
(4.13)
# 1,590
Out of 5,004 analysts
195
Total ratings
65.6%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $180 → $190 | $172.79 | +9.96% | 5 | Aug 27, 2026 | |
| QDEL QuidelOrtho | Reiterated: Sell | $12 | $10.94 | +9.69% | 20 | Aug 24, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $32 → $35 | $32.80 | +6.71% | 3 | Aug 10, 2026 | |
| QGEN Qiagen | Reiterated: Buy | $50 | $44.18 | +13.17% | 20 | Aug 10, 2026 | |
| SHC Sotera Health Company | Reiterated: Hold | $16 → $18 | $18.34 | -1.85% | 15 | Aug 10, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $38 → $50 | $85.71 | -41.66% | 5 | Aug 10, 2026 | |
| NTRA Natera | Reiterated: Buy | $315 → $360 | $412.56 | -12.74% | 6 | Aug 7, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $145 → $130 | $123.08 | +5.62% | 8 | Aug 6, 2026 | |
| BRKR Bruker | Reiterated: Buy | $65 → $60 | $64.18 | -6.51% | 4 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $30 → $25 | $31.98 | -21.83% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $110 | $151.11 | -27.21% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $370 → $400 | $433.54 | -7.74% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $160 → $310 | $292.84 | +5.86% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $177.25 | +10.01% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $155 → $165 | $172.33 | -4.25% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $270.00 | -14.81% | 8 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1,200 → $1,400 | $1,511.64 | -7.39% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $45 | $85.01 | -47.07% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $15.25 | -21.31% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $255 → $285 | $270.37 | +5.41% | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $175 | $189.68 | -7.74% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 → $690 | $675.00 | +2.22% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $220 | $224.49 | -2.00% | 8 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.93 | n/a | 5 | Aug 9, 2024 |
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $172.79
Upside: +9.96%
QuidelOrtho
Aug 24, 2026
Reiterated: Sell
Price Target: $12
Current: $10.94
Upside: +9.69%
Alamar Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $32.80
Upside: +6.71%
Qiagen
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $44.18
Upside: +13.17%
Sotera Health Company
Aug 10, 2026
Reiterated: Hold
Price Target: $16 → $18
Current: $18.34
Upside: -1.85%
10x Genomics
Aug 10, 2026
Reiterated: Hold
Price Target: $38 → $50
Current: $85.71
Upside: -41.66%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $315 → $360
Current: $412.56
Upside: -12.74%
BillionToOne
Aug 6, 2026
Reiterated: Buy
Price Target: $145 → $130
Current: $123.08
Upside: +5.62%
Bruker
Aug 6, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $64.18
Upside: -6.51%
Caris Life Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $31.98
Upside: -21.83%
Aug 6, 2026
Reiterated: Hold
Price Target: $90 → $110
Current: $151.11
Upside: -27.21%
Aug 6, 2026
Reiterated: Hold
Price Target: $370 → $400
Current: $433.54
Upside: -7.74%
Aug 5, 2026
Upgraded: Buy
Price Target: $160 → $310
Current: $292.84
Upside: +5.86%
Aug 4, 2026
Reiterated: Buy
Price Target: $195
Current: $177.25
Upside: +10.01%
Aug 4, 2026
Reiterated: Hold
Price Target: $155 → $165
Current: $172.33
Upside: -4.25%
Aug 4, 2026
Reiterated: Buy
Price Target: $230
Current: $270.00
Upside: -14.81%
Aug 4, 2026
Reiterated: Hold
Price Target: $1,200 → $1,400
Current: $1,511.64
Upside: -7.39%
Aug 4, 2026
Reiterated: Hold
Price Target: $50 → $45
Current: $85.01
Upside: -47.07%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $12
Current: $15.25
Upside: -21.31%
Jul 29, 2026
Rated: Buy
Price Target: $255 → $285
Current: $270.37
Upside: +5.41%
Jul 29, 2026
Rated: Buy
Price Target: $165 → $175
Current: $189.68
Upside: -7.74%
Jul 28, 2026
Reiterated: Buy
Price Target: $600 → $690
Current: $675.00
Upside: +2.22%
Jul 23, 2026
Reiterated: Buy
Price Target: $245 → $220
Current: $224.49
Upside: -2.00%
Aug 9, 2024
Reiterated: Hold
Price Target: $6 → $5
Current: $3.93
Upside: n/a